Results of Pilot Study That Evaluated Postoperative Recovery in Abdominal Surgery Patients Presented at the American Society of Colon and Rectal Surgery Conference 2023

MOUNTAIN VIEW, Calif., June 6, 2023 – G-Tech Medical today announced an oral presentation of an abstract entitled Associating Myoelectric Activity Following Colorectal Surgery with Return of Bowel Function at the American Society of Colon and Rectal Surgeons (ASCRS) Annual Meeting held in Seattle June 3-6. Arabella Dill-Macky of Yale authored and presented the abstract. Dr. Ira Leeds  of Yale was the principal investigator of the study conducted in collaboration with G-Tech.

The G-Tech Wireless Patch System (WPS) is a non-invasive diagnostic solution that helps physicians assess patient motility by monitoring myoelectrical signals from the stomach, small intestines and colon over multiple days.

In the study, 24 patients who had undergone colectomies or enterectomies with anastomosis were enrolled. Three patches were applied to the patients’ abdomens within 4 hours after surgery, where they remained throughout the hospital stay. The G-Tech app collected myoelectric signals that have been shown to correlate with stomach (2.4-4 CPM), small bowel (5-12 CPM) and colon (12-28 CPM) signatures, along with patient entered information such as first liquid and solid meals and first bowel movement. Patient demographic and clinical information was also collected. Length of Stay for each patient was broken into expected (< 5 days) and late (>5 days) groups.

The small bowel and colon myoelectrical signals had statistically significant differences between the expected and late groups. For the small bowel signal there was significance at 12-, 18- and 24-hours after surgery, and for the colon signal there was significance at 6-, 12-, 18- and 24- hours after surgery.

“The results demonstrate that higher small intestinal and colonic myoelectric activity in the early stages of recovery is associated with a shorter length of stay,” said Dr. Leeds.  “Further use of gastrointestinal myoelectric signaling may help inform clinical decisions regarding the discharge of patients even in the first 12 hours after surgery.”

“These results are consistent with our earlier clinical studies of other types of abdominal surgery patients,”  said Steve Axelrod, CEO of G-Tech.  “Demonstrating that the myoelectric signals can be predictive of recovery time for colorectal surgery patients represents another key finding. We are currently working on several additional studies that are enrolling patients with various other surgery types to further validate that the G-Tech WPS has broad applicability in helping shorten Length of Stay.”

At the ASCRS meeting a poster by Dill-Macky entitled Assessing Views on Myoelectric Activity Data for Discharge Readiness After Colorectal Surgery was also presented. The poster reviewed the opinions of 30 surgeons and surgery residents regarding the most effective methods for communicating timely  myolectric signal information to physicians.

 

 About G-Tech Medical

G-Tech Medical, Inc. is a medical device company dedicated to developing low-cost, non-invasive gastrointestinal monitoring solutions for patients with chronic GI disorders. G-Tech’s wearable wireless patch will provide patient-specific motility data to physicians, helping them assess underlying causes of GI disorders and develop targeted therapies. The company is headquartered at Fogarty Innovation, 2495 Hospital Drive, Suite 300, Mountain View, CA 94040. For further information, please visit www.GTechMedical.com or email info@gtechmedical.com.

#   #   #

Media Contact

Rob Kirby

G-Tech Medical

rob@gtechmedical.com

 

Interim Results of Study That Used Non-invasive Wireless Patches to Monitor Myoelectric Activity of Crohn’s Disease Patients in Flare and Remission

MOUNTAIN VIEW, Calif., May 9, 2023 – G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced presentation of a poster at the Digestive Disease Week Annual Meeting held in Chicago May 6-9. Wireless Patches Reveal Differences in Colonic Motility Between Acute Crohn’s Disease Patients and Healthy Controls demonstrated findings from a study conducted by researchers at Stanford University in collaboration with G-Tech.

The G-Tech Wireless Patch System (WPS) is a non-invasive diagnostic solution that helps physicians assess patient motility by monitoring myoelectrical signals from the stomach, small intestine and colon over multiple days. G-Tech received FDA 510(k) clearance for the WPS in 2022.

In the study, 66 Crohn’s Disease patients and 38 healthy controls wore three abdominal patches for three to six consecutive days while pursuing regular daily activities. Each patch continuously recorded myoelectric activity from the stomach, small intestine and colon. Other information collected included patient meal intake, bowel movements, and lab and endoscopy results. Dr. Sidhartha Sinha, an IBD specialist and Director of Digital Health and Innovation at Stanford’s Division of Gastroenterology and Hepatology, led the project for Stanford.

Results from the study show distinguishing characteristics between patients in an acute flare condition as determined by their physician, and healthy controls. Patients in active flare show significantly lower colon activity, on average, than healthy controls. Patients who reported moderate symptoms, according to the IBS Severity Scoring System (IBS-SSS), had lower colon activity than healthy controls, and patients with severe symptoms had even lower colon activity. Compared to healthy controls, the reduced colon activity in Crohn’s Disease patients becomes more statistically significant as the severity score increases.

“This study demonstrates that the G-Tech WPS offers a unique way to understand the physiological changes occurring in patients with Crohn’s Disease in active flare,” said lead author Lindsay Axelrod of G-Tech.

“Non-invasive biomarkers of IBD are important monitoring tools, as the AGA emphasized in its recently published biomarkers guidelines,” said Steve Axelrod, CEO of G-Tech. “The ability of the G-Tech WPS to monitor motility non-invasively over multiple days could be a significant addition to this approach.”

The study was funded by the Leona M. and Harry B. Helmsley Charitable Trust.

About G-Tech Medical
G-Tech Medical, Inc. is a medical device company dedicated to developing low-cost, non-invasive gastrointestinal monitoring solutions for patients with chronic GI disorders. G-Tech’s wearable wireless patch will provide patient-specific motility data to physicians, helping them assess underlying causes of GI disorders and develop targeted therapies. The company is headquartered at Fogarty Innovation, 2495 Hospital Drive, Suite 300, Mountain View, CA 94040. For further information, please visit www.GTechMedical.com or email info@gtechmedical.com.
# # #
Media Contact
Rob Kirby
G-Tech Medical
rob@gtechmedical.com

Results of Pilot Study That Monitored Patients with Functional Dyspepsia, Gastroparesis and Vomiting Presented at Digestive Disease Week 2023

MOUNTAIN VIEW, Calif., May 10, 2023 (GLOBE NEWSWIRE) — G-Tech Medical today announced an oral presentation of an abstract entitled A Novel, Non-invasive, 6-day Wireless Motility Patch System Demonstrates Unique Myoelectrical Patterns in Patients with Functional Dyspepsia, Gastroparesis, and Vomiting at the recent Digestive Disease Week Annual Meeting held in Chicago May 6-9. Dr. Brian Lacy of Mayo Clinic, the principal investigator of the study, presented findings from the study conducted in collaboration with G-Tech.


The G-Tech Wireless Patch System (WPS) is a non-invasive diagnostic solution that helps physicians assess patient motility by monitoring myoelectrical signals from the stomach, small intestines and colon over multiple days. G-Tech received FDA 510(k) clearance for the WPS in 2022.


In the study, 23 patients with symptoms of functional dyspepsia, nausea, vomiting or gastroparesis underwent a four-hour gastric scintigraphy test. In addition, G-Tech’s patches were applied to the patient abdomen prior to scintigraphy. Patients continued to wear the patches for a mean of 4.8 days.
Patients with delayed gastric emptying at four hours had low gastric myoelectrical activity. In addition to demonstrating concordance with the gastric scintigraphy test, the G-Tech test also showed that patients with functional dyspepsia had relatively low gastric and intestinal myoelectric activity. Patients with nausea and vomiting had higher intestinal myoelectrical activity. Finally, patients with functional dyspepsia had reduced meal response throughout the GI tract compared to those with nausea and vomiting alone.


“It was a privilege to work with Dr. Lacy to help interpret our findings and compare them to gastric scintigraphy, which is the current gold standard test for delayed gastric emptying,” said Dr. Anand Navalgund, the Director of Clinical Science for G-Tech.


“The results are promising,” said Steve Axelrod, CEO of G-Tech. “Our ability to monitor GI patients noninvasively over multiple days has clear advantages. We will soon begin working on an expanded study to help us learn more about stratifying patients with unclear diagnoses into distinct groups of patients with delayed gastric emptying and other diagnoses, such as functional dyspepsia.”


About G-Tech Medical
G-Tech Medical, Inc. is a medical device company dedicated to developing low-cost, non-invasive gastrointestinal monitoring solutions for patients with chronic GI disorders. G-Tech’s wearable wireless patch will provide patient-specific motility data to physicians, helping them assess underlying causes of GI disorders and develop targeted therapies. The company is headquartered at Fogarty Innovation, 2495 Hospital Drive, Suite 300, Mountain View, CA 94040. For further information, please visit www.GTechMedical.com or email info@gtechmedical.com.


Media Contact
Rob Kirby
G-Tech Medical
rob@gtechmedical.com

New Journal Publication Demonstrates Concordance of Signals Between the G-Tech Noninvasive Patch System and Internally Implanted Electrodes

MOUNTAIN VIEW, Calif., June 29, 2022 – G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced publication of a peer-reviewed article in the Journal of Surgical Research. Gastrointestinal Myoelectric Measurements via Simultaneous External and Internal Electrodes in Pigs presents findings from a study conducted by researchers at Stanford University in collaboration with G-Tech. The article is available online at  https://authors.elsevier.com/c/1fIjQ578XaM9Y and will appear in the Journal of Surgical Research’s November 2022 edition.

In the study researchers implanted electrodes in the stomach, small intestines and colon of Yucatan pigs and placed G-Tech patches on the pigs’ skin surface. The purpose of the study was to assess whether G-Tech’s external patch system could assess myoelectric signals and determine the organ of origin (stomach, small intestines or colon) noninvasively. The results “demonstrated a clear congruence between external and internal measurements.”

“This was an important project for us, and it was a pleasure to work with the Stanford team,” said Steve Axelrod, CEO of G-Tech. “We have previously validated our technology in studies comparing our data to antroduodenal and colonic manometry and to SmartPill data in humans. Demonstrating direct correlation between the data recorded by internal electrodes and our external electrodes in a pig model further substantiates our approach.”

The article pointed out that “Currently, there is no accurate noninvasive measurement system to diagnose gastrointestinal (GI) motility disorders.” The authors mentioned that such a system would be essential in developing neuro-stimulation treatments for motility disorders and could be used for post-operative ileus (POI) as well.

This article is the fifth peer-reviewed article covering G-Tech’s Wireless Patch System, and the first to focus primarily on technical validation. Three previous articles centered on clinical trials that demonstrated the system’s ability to detect early signals of gut function recovery following surgery, which can potentially be used to allow patients to leave the hospital earlier and reduce post-operative ileus and readmissions. Another article was a feasibility paper describing several human case studies that suggested the G-Tech system could help ambulatory patients in a variety of ways, including determining whether GI drugs are having the intended effect.

“We’re really just starting to scratch the surface in terms of the various use cases for which our system can provide real value,” said Axelrod.

 About G-Tech Medical

G-Tech Medical, Inc. is an early-stage medical device company dedicated to developing low-cost, non-invasive gastrointestinal monitoring solutions for patients with chronic GI disorders. G-Tech’s wearable wireless patch will provide patient-specific motility data to physicians, helping them assess underlying causes of GI disorders and develop targeted therapies. The company is headquartered at Fogarty Innovation, 2495 Hospital Drive, Suite 300, Mountain View, CA 94040. For further information, please visit www.GTechMedical.com or email info@gtechmedical.com.

#   #   #

Media Contact

Rob Kirby

G-Tech Medical

rob@gtechmedical.com

Posters Presented at DDW 2022 Demonstrate G-Tech System Motility Measurements Correlate with Antroduodenal Manometry Measurements and Can be Used to Characterize Colon Motility Alteration

MOUNTAIN VIEW, Calif., May 26, 2022G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced that two posters were presented at Digestive Disease Week Conference held in San Diego in from May 21 through May 24.

The first poster, entitled Wireless non-invasive patches detect phase III of the migrating motor complex in response to octreotide administration, reported on a study performed in humans by researchers from the Children’s Hospital of Philadelphia and GTech.  The key finding of the study was that the G-Tech patches detected spectral peaks in myoelectric activity at the same frequencies detected by simultaneous antroduodenal manometry after octreotide administration. These frequencies (11-12 cpm) have previously been associated with small bowel activity.

The second poster, entitled Development and Characterization of an opioid-induced constipation (OIC) model in swine: use of G-Tech wireless non-invasive patches to monitor colonic myoelectrical activity (CMA), reported on a study performed by researchers from UCLA and G-Tech. The study described the development of a valid model of OIC in pigs. The patches demonstrated sensitivity to detect effects of loperamide on the porcine CMA and showed potential to help characterize colon motility alteration as in constipation.

These posters are only the most recent in a series of over 20 posters, multiple invited talks and five peer-reviewed journal articles that demonstrate validity of the underlying measurement of GI motility and its potential for broad, game-changing clinical application.

“We’re extremely fortunate to collaborate with such esteemed partners in the academic community to help move motility science forward,” said Steve Axelrod, CEO of G-Tech.

The G-Tech WPS is a tool that provides gastric and intestinal myoelectrical activity measurements to be used at the discretion of the Physician or Clinical researcher to aid in the diagnosis and evaluation of gastrointestinal disorders and dysfunctions.

 About G-Tech Medical

G-Tech Medical, Inc. is an early-stage medical device company dedicated to developing low-cost, non-invasive gastrointestinal monitoring solutions for patients with chronic GI disorders. G-Tech’s wearable wireless patch will provide patient-specific motility data to physicians, helping them assess underlying causes of GI disorders and develop targeted therapies. The company is headquartered at Fogarty Innovation, 2495 Hospital Drive, Suite 300, Mountain View, CA 94040. For further information, please visit www.GTechMedical.com or email info@gtechmedical.com.

#   #   #

Media Contact

Rob Kirby

G-Tech Medical

rob@gtechmedical.com

Two Posters to be Presented at Digestive Disease Week 2022

MOUNTAIN VIEW, Calif., March 15, 2022G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced that two posters have been accepted for presentation at the upcoming Digestive Disease Week Conference to be held in San Diego in from May 21 through May 24.

The first poster, entitled Wireless non-invasive patches detect phase III of the migrating motor complex in response to octreotide administration, reports on a study performed by researchers from the Children’s Hospital of Philadelphia and G-Tech. The second poster, entitled Development and Characterization of an opioid-induced constipation (OIC) model in swine: use of G-Tech wireless non-invasive patches to monitor colonic myoelectrical activity (CMA), reports on a study performed by researchers from UCLA and G-Tech.

“When these posters are presented, over 25 scientific presentations and posters and 4 clinical articles will have been published on the G-Tech motility solution,” said Steve Axelrod, CEO of G-Tech. “We’re extremely fortunate to collaborate with such motivated partners in the academic community to help move motility science forward.”

The G-Tech WPS is a tool that provides gastric and intestinal myoelectrical activity measurements to be used at the discretion of the Physician or Clinical researcher to aid in the diagnosis and evaluation of gastrointestinal disorders and dysfunctions.

 

About G-Tech Medical

G-Tech Medical, Inc. is an early-stage medical device company dedicated to developing low-cost, non-invasive gastrointestinal monitoring solutions for patients with chronic GI disorders. G-Tech’s wearable wireless patch will provide patient-specific motility data to physicians, helping them assess underlying causes of GI disorders and develop targeted therapies. The company is headquartered at Fogarty Innovation, 2495 Hospital Drive, Suite 300, Mountain View, CA 94040. For further information, please visit www.GTechMedical.com or email info@gtechmedical.com.

 

#   #   #

 

Media Contact

Rob Kirby

G-Tech Medical

rob@gtechmedical.com

 

G-Tech Medical Receives FDA Clearance for its Gastrointestinal Motility Monitoring System

MOUNTAIN VIEW, Calif., January 13, 2022G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Wireless Patch System (WPS) for non-invasive myoelectric activity measurement.

The G-Tech WPS is a tool that provides gastric and intestinal myoelectrical activity measurements to be used at the discretion of the Physician or Clinical researcher to aid in the diagnosis and evaluation of gastrointestinal disorders.

“We are excited to receive our first regulatory clearance,” said Steve Axelrod, CEO of G-Tech. “This is a key achievement in support of our ultimate goal of providing a motility solution that localizes the sources and identifies the nature of GI disorders.”

Gastrointestinal (GI) motility is the underlying factor in a wide range of disorders and dysfunction experienced by tens of millions in the U.S. GI disorders include inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and other functional gastrointestinal disorders (FGID’s).1 GI dysfunctions are also prevalent during recovery from abdominal surgery which can lead to post-operative ileus (POI).2

Current motility technologies are typically limited in scope, invasive and only sample for a brief time period in a non-physiological setting, such as a hospital or physician office. The G-Tech product, in contrast, measures myoelectrical signals from the stomach, small intestines and colon over multiple days non-invasively in a variety of settings.

G-Tech will continue to prioritize investment in clinical trials in the near term.

“It’s all about the data. Developing a large, proprietary data set which we can mine and analyze to drive new learnings, and correlate motility with specific GI issues, is key for us,” said Axelrod. “We truly believe our ‘EKG for the Gut’ will become a standard of care in gastroenterology over time. Growing our patient motility database is the shortest path to that future.”

  1. Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL, Jensen ET, Shaheen NJ, Barritt AS, Lieber SR, Kochar B, Barnes EL, Fan YC, Pate V, Galanko J, Baron TH, Sandler RS. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018. Gastroenterology. 2019 Jan;156(1):254-272.e11. doi: 10.1053/j.gastro.2018.08.063. Epub 2018 Oct 10. Erratum in: Gastroenterology. 2019 May;156(6):1936. PMID: 30315778; PMCID: PMC6689327.
  1. Nachlas, MARVIN M., M. Tewfic Younis, C. Pio Roda, and JOSEPH J. Wityk. “Gastrointestinal motility studies as a guide to postoperative management.” Annals of surgery 175, no. 4 (1972): 510. 

About G-Tech Medical

G-Tech Medical, Inc. is an early-stage medical device company dedicated to developing low-cost, non-invasive gastrointestinal monitoring solutions for patients with chronic GI disorders. G-Tech’s wearable wireless patch will provide patient-specific motility data to physicians, helping them assess underlying causes of GI disorders and develop targeted therapies. The company is headquartered at Fogarty Innovation, 2495 Hospital Drive, Suite 300, Mountain View, CA 94040. For further information, please visit www.GTechMedical.com or email info@gtechmedical.com.

#   #   #

Media Contact

Rob Kirby

G-Tech Medical

rob@gtechmedical.com

 

 

G-Tech Medical Appoints Rob Kirby as Vice President of Strategy and Business Development

Mountain View, Calif., November 5, 2021 – G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced that Rob Kirby has been hired as Vice President of Strategy and Business Development.

“We are very excited that Rob has joined our company,” said Steve Axelrod, CEO of G-Tech. “As a startup we know that every hire is critical, and that adding versatile performers is especially important. Rob has demonstrated a rare ability in his career to succeed in many different roles. It’s also already clear that he will have a strong cultural fit with our small but growing team.”

Rob has worked for over 20 years in medical device startup companies. His breadth of experience includes strategic planning, business development, marketing and cross-functional program leadership. He has held leadership roles at Xoft, TAE Life Sciences and other device companies. Rob holds a BS degree in Mechanical Engineering from UC Davis and an MBA with a strategic planning emphasis from UC Riverside.

“I’m absolutely thrilled to join G-Tech,” said Kirby. “I have known Steve for many years. I’ve been keeping a close eye on G-Tech’s progress from the days when the product was just an idea in Steve’s head, through these past several years of product development and clinical trials. It is truly remarkable how far such a small team has come in such a short amount of time. The chance to join the company at this pivotal time and play a role in commercializing this technology is a rare opportunity.”

G-Tech has developed a wireless wearable patch that measures GI motility of the stomach, small intestines and colon non-invasively over multiple days. Over 600 tests have been run under IRB approvals, resulting in 4 peer reviewed publications and numerous conference posters.

“Until now our team has focused on building the technology platform and confirming its clinical utility,” added Axelrod. “Rob’s hire is significant for us because it marks a turning point for G-Tech. We have succeeded in developing the GI motility tool that we set out to create. Now we can refocus our energy on building out the business so that our GI motility solution will positively impact patient’s lives and will potentially become a standard of care.”

The G-Tech patch system is not currently available for sale and does not have regulatory clearance or approval.

 

About G-Tech Medical

G-Tech Medical, Inc. is an early-stage medical device company dedicated to developing low-cost, non-invasive, diagnostic solutions for patients with chronic gastrointestinal disorders. G-Tech’s wearable patch-based “EKG for the Gut” will be used to diagnose underlying causes of GI disorders, allowing physicians to develop targeted therapies, thereby speeding relief to patients and significantly lowering the cost of health care. The company is headquartered at Fogarty Innovation, 2495 Hospital Drive, Suite 300, Mountain View, CA 94040. For further information, please visit www.GTechMedical.com or email info@gtechmedical.com.

 

#   #   #

 

Media Contact

Steve Axelrod

G-Tech Medical

650 269-1479

steve.axelrod@gtechmedical.com

G-Tech Medical Presents at the 2020 Digestive Disease Week

DDW 2020 logoG-Tech Medical will be in Chicago in May at the 2020 Digestive Disease Week with two posters in collaboration with researchers at Stanford University.

The first with findings from an ongoing longitudinal study of patients with Crohn’s disease demonstrates the uniqueness of each patient’s physiological gut print and its reproducibility as captured by G-Tech’s non-invasive patch system. The second abstract presents preliminary findings from a study measuring digestive vagal dysfunction in a patient population with gastroparesis.

G-Tech Medical’s Lindsay Axelrod Presents Her Abstract

Crohn's & Colitis Foundation logoG-Tech Medical’s Lindsay Axelrod presented her abstract with preliminary findings from an ongoing collaborative study with Stanford University supported by the Helmsley Charitable Trust. The study involves using non-invasive wireless electrode patches to read myoelectrical signals from the gut over 3 days in patients with Crohn’s disease. Forty patients presenting in flare, and 30 in remission will be tested at t=0,1,3 and 6 months.